Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07349459
Eligibility Criteria:
Inclusion Criteria:
* Age from 18 to 65 years old.
* Gender: female.
* Positive breast cancer women who are scheduled to receive Doxorubicin.
* Have a good performance status according to the eastern cooperative oncology group with a score of 0-2.
* Normal baseline Echocardiography with left ventricular ejection fraction ≥ 50%.
* Normal renal and liver function tests.
Exclusion Criteria:
* Pregnant or breastfeeding women.
* Women with HER-2 positive of breast cancer.
* Formerly treated with Doxorubicin.
* Patients with a known hypersensitivity to any of the used drugs.
* On other concomitant vitamins or food supplements.
* Valvular heart disease, coronary artery disease, history of congestive heart failure or cardiomyopathy.
* Impaired Left ventricular systolic function in which the Left Ventricular Ejection Fraction \< 50%.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07349459
Study Brief:
Protocol Section:
NCT07349459